NASDAQ: AEGR
Price:
28.75
Change:
+ 1.07
Day High:
28.92
Day Low:
27.82
Volume:
978,000
4:00 PM ET on Jul 23, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Overview

Stock price graph

Aegerion Pharmaceuticals is an emerging biopharmaceutical company focused on the development and commercialization of novel life-altering therapeutics for rare and often fatal diseases. 

Recent News

Germany's Federal Joint Committee (G-BA) grants LOJUXTA® (lomitapide) hard capsules a "no additional benefit" assessment based upon technical matters within the value dossier submitted. As expected, the decision is consistent with G-BA's preliminary assessment granted in March of this year. The Company plans to re-submit the dossier following the expiration of the decision on June 15, 2015.

View all »   RSSRecent Releases

Jul 22, 2014
Aegerion Pharmaceuticals to Announce Second Quarter 2014 Financial Results on Tuesday, July 29

Jul 9, 2014
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

View all »Events & Presentations

Jul 29, 2014 at 5:00 PM ET
Q2 2014 Earnings Conference Call

Latest Annual Report

2013 Annual Report